Mina Koriakos, MBA

Mina Koriakos, MBA, has extensive work experience in financial analysis and reporting. Mina currently serves as a Sr. Financial Analyst, Clinical Operations at Quantum Leap Healthcare Collaborative, where they are responsible for examining cost coverage analysis for new trials and implementing financial workflows.

Prior to their current role, Mina worked at Johnson & Johnson from 2015 to 2021. There, they served as a Senior Financial Analyst in various capacities, including Enterprise Source Finance, Consumer OPEX|NA COE, and FP&A Global reporting. In these roles, they were responsible for budget consolidation, headcount reporting, and financial support for global functions. Mina also worked closely with business partners to manage commercial budgets and identify process improvement opportunities.

Before joining Johnson & Johnson, Mina worked at Dr. Reddy's Laboratories as a Senior Financial Analyst, where they analyzed sales, gross margins, and expenses to optimize value creation and cost control. Mina also provided market trend analysis and supported monthly budget reviews.

Earlier in their career, Mina worked at Novo Nordisk in multiple roles, including Senior Financial Analyst and Finance Associate. In these positions, they analyzed clinical trial payments, managed budgets, and implemented payment systems. Mina also played a key role in cost savings initiatives and data analysis for regulatory compliance.

Overall, Mina Koriakos brings a wealth of experience in financial analysis, budgeting, and process improvement to their current role and previous positions.

Mina Koriakos obtained their Bachelor of Science (B.S.) degree in Business Administration and Management, General from Kean University, where they studied from 2005 to 2009. Mina further pursued their education at Georgian Court University and earned their Master of Business Administration (MBA) degree in 2014.